1 active not recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Fine Lines: new trials by email Literature Review of Fine Lines trials Research Report on Fine Lines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Adipose Cells Therapy Autologous Adipose Cells Therapy - Hair Loss/Baldness, Wrinkle Appearance | Phase 1 / Phase 2 | Recruiting | CERM INC. | 40 | 2025-08-01 | 2025-05-31 |
| A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions KB301, Placebo - Skin Roughness, Wrinkle | Phase 1 | Active not recruiting | Krystal Biotech, Inc. | 85 | 2020-10-07 | 2025-05-13 |
Alopecia (1) · Pigmentation Disorders (1)
Hair Diseases (1) · Hypotrichosis (1) · Pathologic Processes (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
CERM INC. (1) · Krystal Biotech, Inc. (1)
United States (2)
Dr. Abdollah M. Malekzadeh, MD, MD (1) · Dr. Arun Kumar, PhD (1)